NEW YORK (GenomeWeb) –Germany's Scienion and Australia's Axxin today announced a collaboration on an instrument reader system for the analysis of multiplexed microarrays on lateral flow immunoassay strips.
The partnership brings together Scienion's picoliter dispensing technology and Axxin's capabilities in commercializing instruments for point-of-care diagnostics. The firms said that the first joint project will be to develop a colorimetric reader system for multiplexed lateral flow microarrays for POC and R&D applications.
Financial and other details of the deal were not disclosed.
"Combining our expertise and technologies means leveraging integrated solutions from two ends," Sciention CEO Holger Eickhoff said in a statement. "Multiplexing is a vital topic in lateral flow point-of-care diagnostics, and I am convinced that our collaboration will result in breakthrough products in an otherwise mature market."
In June, Scienion partnered with QuantuMDx to commercialize a molecular probe technology. A month later it partnered with Australia-based Anteo to improve reagents for protein microarrays.